This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PRF1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PRF1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~61.4 kDa | |
| Observed band | ~61 kDa | |
| Gel | 10% (catalog PB9155) | |
| Positive control | Spleen (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The PB9155 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human HepG2, human HEL, human Daudi (catalog PB9155) |
| Gel % | 10% (catalog PB9155) |
| Load | 30 ug; reducing conditions (catalog PB9155) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog PB9155) |
| Membrane | nitrocellulose membrane (catalog PB9155) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog PB9155) |
| Primary antibody | PB9155 · 0.5 μg/mL (catalog PB9155) |
| Primary incubation | overnight at 4°C (catalog PB9155) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog PB9155) |
| Secondary incubation | 1.5 hour at RT (catalog PB9155) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog PB9155) |
| Detection | ECL (catalog PB9155) |
PRF1 has a predicted precursor mass of 61.4 kDa and an observed band at ~61 kDa; the cause of their small difference is not established.
| Band at ~61 kDa | Matches the empirical PRF1 band; confirm identity with an appropriate control |
| Band above ~61 kDa | Could reflect occupancy of the N-linked glycosylation sites; a visible shift is unproven |
| Band below ~61 kDa | Could reflect signal-peptide cleavage; the mature band size is not established |
| Broad band or smear | Could reflect variable occupancy of the two N-linked glycosylation sites |
| Little or no band in whole-cell lysate | PRF1 is secreted and also localizes to cytolytic granules |
| UniProt predicted mass | Sets a 61.4 kDa precursor baseline; the observed band is ~61 kDa |
| N-linked glycosylation at Asn205 | May raise apparent mass if occupied; its individual shift is unknown |
| N-linked glycosylation at Asn549 | May raise apparent mass if occupied; its individual shift is unknown |
| Signal peptide at residues 1–21 | Cleavage may lower mature-chain mass relative to the precursor; migration is unmeasured |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Secreted PRF1 or PRF1 concentrated in cytolytic granules may be poorly represented | Check a suitable positive-control lysate and compare cell-associated and released material |
| Band higher than expected | Occupancy of Asn205 or Asn549 may alter migration | Compare matched samples before and after N-glycan removal and verify band identity |
| Band lower than expected | Signal-peptide cleavage could reduce mass, but the mature band size is unknown | Compare with a positive control and verify antibody recognition of the band |
| Broad smear instead of sharp band | Variable N-linked glycosylation is possible but unproven | Compare matched samples before and after N-glycan removal |
| Multiple bands | Different glycosylation or signal-peptide processing states are possible | Compare with a positive control and test N-glycan removal |
| Weak or no signal | Secretion or granule localization may limit PRF1 in the tested fraction | Test a suitable positive control and compare sample fractions |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Spleen | cells in red pulp | High | Protein (IHC) | HPA → |
| Endometrium | cells in endometrial stroma | Medium | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
| Lymph node | non-germinal center cells | Medium | Protein (IHC) | HPA → |
| Oral mucosa | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PRF1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
PB9155 is a human-reactive anti-PRF1 antibody with a supplied Western blot image. Its caption reports an approximately 61 kDa band in human HepG2, HEL, Daudi, and HUH7 whole-cell lysates under reducing conditions. The supplied evidence covers these tested samples only.
Which to pick: PB9155 is the only listed option. Choose it for a human-sample WB design when a reported blot is useful; its image uses four human cell-line lysates. Confirm performance in your own sample and conditions.